Capital Goods Healthcare Sector

Anteris Technologies Global

Market Cap: AU$211.3m

A structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.

Aldeyra Therapeutics

Market Cap: US$134.8m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

Protara Therapeutics

Market Cap: US$134.3m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Vireo Growth

Market Cap: CA$183.6m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Exagen

Market Cap: US$130.3m

Designs, develops, and commercializes various testing products under the AVISE brand in the United States.

Greenwich LifeSciences

Market Cap: US$130.1m

A clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers.

Compugen

Market Cap: US$130.0m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Oneview Healthcare

Market Cap: AU$201.6m

Develops and sells software services for the healthcare sector in Ireland, the United States, Australia, Ireland, the Middle East, and Asia.

KORU Medical Systems

Market Cap: US$129.2m

Develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.

AOTI

Market Cap: UK£95.7m

Produces, rents, and sells medical devices to help resolve severe acute and chronic wounds for customers worldwide.

RAPT Therapeutics

Market Cap: US$127.4m

Operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States.

InfuSystem Holdings

Market Cap: US$126.9m

Through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.

DocGo

Market Cap: US$126.9m

Provides mobile health and medical transportation services in the United States and the United Kingdom.

eXoZymes

Market Cap: US$126.7m

A development stage company focused on building a technology platform that can develop assets that can be reapplied multiple times in different markets with only small changes, while maintaining and capturing new fundamental IP in the application.

Pulmonx

Market Cap: US$126.4m

A commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease.

Editas Medicine

Market Cap: US$125.6m

A clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases.

Jin Medical International

Market Cap: US$125.1m

Engages in the design, development, manufacture, and sale of wheelchair and other living aids products for people with disabilities, the elderly, and people recovering from injury.

Alector

Market Cap: US$125.0m

A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.

Seer

Market Cap: US$124.3m

A life sciences company, develops and commercializes products to decode the biology of the proteome.

Enanta Pharmaceuticals

Market Cap: US$123.8m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

Larimar Therapeutics

Market Cap: US$123.6m

A clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.

Neumora Therapeutics

Market Cap: US$122.1m

A clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.

Lyell Immunopharma

Market Cap: US$121.1m

A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.

Nkarta

Market Cap: US$120.6m

A clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.

Sangamo Therapeutics

Market Cap: US$118.8m

A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.

Nektar Therapeutics

Market Cap: US$117.7m

A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.

Theratechnologies

Market Cap: CA$162.8m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

Lexeo Therapeutics

Market Cap: US$117.2m

A clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States.

Lineage Cell Therapeutics

Market Cap: US$116.7m

A clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally.

American Well

Market Cap: US$116.1m

An enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.

Myomo

Market Cap: US$115.9m

A wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.

Black Diamond Therapeutics

Market Cap: US$115.4m

A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.

InflaRx

Market Cap: US$114.5m

A clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States.

Orchestra BioMed Holdings

Market Cap: US$113.0m

Operates as a biomedical company.

Atossa Therapeutics

Market Cap: US$112.5m

Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.

Sagimet Biosciences

Market Cap: US$110.4m

A clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States.